Cims Pharmaceuticals LLP
About Cims Pharmaceuticals LLP
Data last updated:
Cims Pharmaceuticals LLP is a limited liability partnership (LLP) based in Cochin, Kerala, India, recognised as a startup by DPIIT. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 28 December 2017 and has been in existence for over 9 years.
The LLP is registered with the Registrar of Companies (ROC), Ernakulam, under LLPIN AAL-5451. Its GSTIN is 32AANFC2663A1ZX (Kerala).
The LLP has a total obligation of contribution of ₹5 Lakh. It is led by designated partners Jamsheela Kurikkal and Pavuttakunnan Noufal.
Its latest statement of accounts is for the year ended 31 March 2024. The registered office is at Door No:70/619 Nivya Nagar Lfc Road Kaloor Po Cochin, Kerala, India – 682017.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressDoor No:70/619 Nivya Nagar Lfc Road Kaloor Po Cochin, Kerala, India – 682017
- IndustryChemicals, Manufacturing, Chemicals And Chemical Products
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Designated Partners of Cims Pharmaceuticals LLP
Cims Pharmaceuticals has 2 current designated partners and 2 former designated partners. Current designated partners are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jamsheela Kurikkal Also directs: Cims Healthcare Private Limited | Designated Partner | 20 Jul 2020 | 6 Years 2 Months | Current |
| Pavuttakunnan Noufal Also directs: Cims Healthcare Private Limited | Designated Partner | 28 Dec 2017 | 8 Years 9 Months | Current |
Financials of Cims Pharmaceuticals LLP FY 2024 filings available
Financial Statement Summary of Cims Pharmaceuticals LLP
| Statement of Account and Solvency | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Income and Expenditure | |||||
| Turnover | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Income | •••• | •••• | •••• | •••• | •••• |
| Purchases and Direct Costs | •••• | •••• | •••• | •••• | •••• |
| Personnel Expenses | •••• | •••• | •••• | •••• | •••• |
| Administrative Expenses | •••• | •••• | •••• | •••• | •••• |
| Interest | •••• | •••• | •••• | •••• | •••• |
| Depreciation | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax | •••• | •••• | •••• | •••• | •••• |
| Profit After Tax | •••• | •••• | •••• | •••• | •••• |
| Profit Transferred to Partners | •••• | •••• | •••• | •••• | •••• |
| Assets and Liabilities | |||||
| Partners' Contribution | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Secured Loans | •••• | •••• | •••• | •••• | •••• |
| Unsecured Loans | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Other Liabilities and Provisions | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Loans and Advances | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Cims Pharmaceuticals LLP
| Statement of Account and Solvency | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| Net Profit Margin | •••• | •••• | •••• | •••• | •••• |
| Return on Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Return on Assets | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt to Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Turnover Growth | •••• | •••• | •••• | •••• | •••• |
| Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form 8. The full year-wise statements and ratios of Cims Pharmaceuticals are in the company report.
Financial statements from FY 2018
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Charges & Borrowings of Cims Pharmaceuticals LLP
Cims Pharmaceuticals LLP does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Cims Pharmaceuticals LLP
Employment history and EPFO contributions of people linked to Cims Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Cims Pharmaceuticals LLP
Cims Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 32AANFC2663A1ZX | Kerala | Active | 12 Oct 2018 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Cims Pharmaceuticals LLP
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Cims Pharmaceuticals LLP
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Cims Pharmaceuticals LLP
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Cims Pharmaceuticals LLP
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Cims Pharmaceuticals LLP
Frequently Asked Questions about Cims Pharmaceuticals LLP
Cims Pharmaceuticals is an active limited liability partnership based in Cochin, Kerala, India. The LLP works in manufacturing, within the chemicals industry. It was incorporated on 28 December 2017 (9+ years old) and is registered under LLPIN AAL-5451.
Cims Pharmaceuticals has 2 current designated partners:
- Jamsheela Kurikkal - Designated Partner
- Pavuttakunnan Noufal - Designated Partner
The GSTIN of Cims Pharmaceuticals is 32AANFC2663A1ZX, registered in Kerala.
The LLPIN (Limited Liability Partnership Identification Number) of Cims Pharmaceuticals is AAL-5451. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Cims Pharmaceuticals was incorporated on 28 December 2017, making it 9+ years old. It is registered with the Registrar of Companies, Ernakulam.
Yes, Cims Pharmaceuticals is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
The registered office of Cims Pharmaceuticals is at Door No:70619 Nivya Nagar Lfc Road Kaloor Po Cochin, Kerala, India – 682017.
The total obligation of contribution is ₹5 Lakh.
Cims Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.